Astrazeneca plc ADR (AZN) concluded trading on Wednesday at a closing price of $73.81, with 3.96 million shares of worth about $292.33 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -12.56% during that period and on February 19, 2025 the price saw a loss of about -1.32%. Currently the company’s common shares owned by public are about 3.10B shares, out of which, 3.10B shares are available for trading.
Stock saw a price change of 1.48% in past 5 days and over the past one month there was a price change of 10.83%. Year-to-date (YTD), AZN shares are showing a performance of 12.65% which increased to 17.46% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $62.75 but also hit the highest price of $87.68 during that period. The average intraday trading volume for Astrazeneca plc ADR shares is 5.40 million. The stock is currently trading 3.35% above its 20-day simple moving average (SMA20), while that difference is up 7.82% for SMA50 and it goes to -1.59% lower than SMA200.
Astrazeneca plc ADR (NASDAQ: AZN) currently have 3.10B outstanding shares and institutions hold larger chunk of about 16.79% of that.
The stock has a current market capitalization of $228.90B and its 3Y-monthly beta is at 0.43. PE ratio of stock for trailing 12 months is 32.75, while it has posted earnings per share of $2.25 in the same period. Its PEG reads 2.91 and has Quick Ratio of 0.74 while making debt-to-equity ratio of 0.74. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for AZN, volatility over the week remained 1.54% while standing at 1.47% over the month.
Stock’s fiscal year EPS is expected to rise by 10.54% while it is estimated to increase by 11.72% in next year. EPS is likely to shrink at an annualized rate of 11.26% for next 5-years, compared to annual growth of 34.63% made by the stock over the past 5-years.
Stock get a Sell rating from Deutsche Bank on September 13, 2024.
